» Articles » PMID: 19995099

Sedative Load Among Long-term Care Facility Residents with and Without Dementia: a Cross-sectional Study

Overview
Date 2009 Dec 10
PMID 19995099
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: People with cognitive impairment are particularly susceptible to adverse drug events linked to sedative and psychotropic drugs. A model to calculate sedative load has been developed to quantify the cumulative effect of taking multiple drugs with sedative properties. The objective of this study was to describe the sedative load and use of sedative and psychotropic drugs among long-term care facility residents with and without dementia.

Methods: Cross-sectional data were collected from all 53 long-term care wards in Helsinki, Finland, in September 2003. Of the 1444 eligible residents, consent to participate was obtained for 1087 (75%) residents. Medication and diagnostic data were available for 1052 residents. All drugs were classified using the Anatomical Therapeutic Chemical (ATC) classification system. Sedative load was calculated for each resident using a previously published four-group model.

Results: Of the 1052 residents, 781 (74.2%) were determined to have dementia. Residents with and without dementia had a similar sedative load (mean 3.0 vs 2.7, p = 0.267), but residents with dementia were taking fewer drugs than residents without dementia (mean 6.7 vs 7.4, p = 0.011). Residents with dementia were more frequent users of antipsychotics (42.8% vs 32.8%, p = 0.004), but less frequent users of antidepressants (35.6% vs 46.1%, p = 0.002) and sedative-hypnotics (22.8% vs 27.7%, p = 0.003) than residents without dementia. The most frequently used primary sedatives among people with dementia were temazepam (n = 122, 15.6%), oxazepam (n = 98, 12.5%) and lorazepam (n = 95, 12.2%). The most frequently used drugs with sedation as a prominent adverse effect or preparations with a sedating component among people with dementia were citalopram (n = 183, 23.4%), risperidone (n = 155, 19.8%) and olanzapine (n = 73, 9.3%).

Conclusions: Residents with dementia were less frequent users of sedative-hypnotic drugs than residents without dementia. However, residents with and without dementia had a similar sedative load. Clinicians should be aware of the extent to which all individual drugs, not only those prescribed for intentional sedation, contribute to a resident's sedative load. The very high rates of sedative and psychotropic use observed in long-term care facility residents highlight the need for new strategies to optimize drug use.

Citing Articles

Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.

Aguera-Ortiz L, Babulal G, Bruneau M, Creese B, DAntonio F, Fischer C J Alzheimers Dis. 2022; 88(4):1203-1228.

PMID: 35786651 PMC: 9484097. DOI: 10.3233/JAD-215483.


Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models.

Al Rihani S, Deodhar M, Darakjian L, Dow P, Smith M, Bikmetov R Drugs Aging. 2021; 38(11):977-994.

PMID: 34751922 PMC: 8592980. DOI: 10.1007/s40266-021-00895-x.


Antipsychotic Use in Dementia.

Kirkham J, Sherman C, Velkers C, Maxwell C, Gill S, Rochon P Can J Psychiatry. 2017; 62(3):170-181.

PMID: 28212496 PMC: 5317021. DOI: 10.1177/0706743716673321.


Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study.

Lalic S, Jamsen K, Wimmer B, Tan E, Hilmer S, Robson L Eur J Clin Pharmacol. 2016; 72(9):1117-24.

PMID: 27251360 DOI: 10.1007/s00228-016-2075-4.


Managing agitation using nonpharmacological interventions for seniors with dementia.

Janzen S, Zecevic A, Kloseck M, Orange J Am J Alzheimers Dis Other Demen. 2013; 28(5):524-32.

PMID: 23813608 PMC: 10852721. DOI: 10.1177/1533317513494444.


References
1.
Lesen E, Petzold M, Andersson K, Carlsten A . To what extent does the indicator "concurrent use of three or more psychotropic drugs" capture use of potentially inappropriate psychotropics among the elderly?. Eur J Clin Pharmacol. 2009; 65(6):635-42. DOI: 10.1007/s00228-009-0623-x. View

2.
Martikainen P, Moustgaard H, Murphy M, Einio E, Koskinen S, Martelin T . Gender, living arrangements, and social circumstances as determinants of entry into and exit from long-term institutional care at older ages: a 6-year follow-up study of older Finns. Gerontologist. 2009; 49(1):34-45. DOI: 10.1093/geront/gnp013. View

3.
Brown M, Lapane K, Luisi A . The management of depression in older nursing home residents. J Am Geriatr Soc. 2002; 50(1):69-76. DOI: 10.1046/j.1532-5415.2002.50010.x. View

4.
Hilmer S, McLachlan A, Le Couteur D . Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007; 21(3):217-30. DOI: 10.1111/j.1472-8206.2007.00473.x. View

5.
Holmquist I, Svensson B, Hoglund P . Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol. 2003; 59(8-9):669-76. DOI: 10.1007/s00228-003-0679-y. View